Riskpilot← Back to searchSign inGet full accessAlnylam Sweden AB
ABActiveOrg 5590866686Olof Palmes Gata 29Wholesale of pharmaceutical and medical goods · NACE 4646Est. 20165-9 employees
Revenue 2024
SEK 114,8M
-11% vs 2023
EBITDA margin
2.4%
+52% vs 2023
Equity ratio
9.6%
Financial strength
Net profit 2024
SEK 2M
+41% vs 2023
| Revenue | SEK 114,8M | -11% |
| EBITDA | SEK 2,8M | +52% |
| Net profit | SEK 2M | +41% |
| Total assets | SEK 102M | +8% |
| Equity | SEK 9,8M | +25% |
| Employees | — | — |
Legal name
Alnylam Sweden AB
Org number
5590866686
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
23 november 2016
Share capital
SEK 150 000
Employees
5-9
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Bolaget skall utveckla, marknadsföra, kommersialisera och bedriva handeln med läkemedel i Sverige och utomlands samt bedriva därmed förenlig verksamhet.
Address
Olof Palmes Gata 29
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 54 360 | 96 367 | 112 425 | 129 349 | 114 834 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 1 454 | 1 119 | 1 469 | 1 827 | 2 779 |
| Depreciation & amort. | −22 | −0 | −0 | −0 | −0 |
| EBIT | 1 432 | 1 119 | 1 469 | 1 827 | 2 779 |
| Net financials | 837 | −40 | −3 | 33 | −49 |
| Profit before tax | 2 269 | 1 079 | 1 465 | 1 860 | 2 730 |
| Tax | −336 | −264 | −399 | −457 | −758 |
| Net profit | 1 933 | 815 | 1 066 | 1 403 | 1 972 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 38 816 | 72 437 | 87 323 | 94 497 | 102 010 |
| Equity | 4 572 | 5 386 | 6 453 | 7 855 | 9 828 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 34 244 | 67 051 | 80 871 | 86 642 | 92 182 |
| Total debt | 34 244 | 67 051 | 80 871 | 86 642 | 92 182 |
EBITDA margin
2.4%
This company
15.8%
Market median
-85% vs market
20202024
Equity ratio
9.6%
This company
38.2%
Market median
-75% vs market
20202024
Return on equity
20.1%
This company
18.4%
Market median
+9% vs market
20202024
Net profit margin
1.7%
This company
8.1%
Market median
-79% vs market
20202024
Asset turnover
1.13×
This company
1.12×
Market median
+1% vs market
20202024
Debt / equity
9.38×
This company
0.62×
Market median
-1413% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
AG Chief Auditor | Chief Auditor | 2022 |
| Former (1) | ||
OR Chief Auditor | Chief Auditor | 2022 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2020 | |
| Chairman | 2023 | |
| Board of Directors | 2025 | |
| Former (6) | ||
| Board of Directors | 2020 – 2021 | |
| Chairman | 2022 – 2023 | |
| Chairman | 2020 – 2022 | |
| Board of Directors | 2022 – 2022 | |
| Deputy Board Member | 2022 – 2022 | |
| Board of Directors | 2021 – 2025 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Alnylam Sweden AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ola Rasmus Lindholm | Chief Auditor | 0 companies |
| Anna Gabriella Hermansson | Chief Auditor | 0 companies |
| Theresa Heggie | Board of Directors | 0 companies |
| Thomas Ivar Wallman | Board of Directors | 0 companies |
| David Jones | Chairman | 0 companies |
| Thomas Andreas Kruijver | Chairman | 0 companies |
| Katarzyna Maria Witkos | Board of Directors | 0 companies |
| Jan Peder Westerblad | Chairman | 0 companies |
| Arianna Greco | Board of Directors | 0 companies |
| Anna Helena Spennare | Deputy Board Member | 0 companies |
| William John Eliot | Board of Directors | 0 companies |